BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  GlaxoSmithKline Announces Phase II Data of a Single One-Week Course of Frontline Treatment with the BEXXAR(R) Therapeutic Regimen

  June 5, 2007

   · 

  9 min read
• Drug Development

  Antigenics Inc. (New York)'s QS-21 Stimulon(R) Adjuvant Enters Phase 3 Clinical Trial of GlaxoSmithKline’s Novel Cancer Immunotherapeutic in Non-Small Cell Lung Cancer

  June 5, 2007

   · 

  1 min read
• Drug Development

  NPS Pharmaceuticals, Inc. Announces Progression of the Calcilytics Development Program in Osteoporosis by GlaxoSmithKline

  June 5, 2007

   · 

  4 min read
• Drug Development

  GlaxoSmithKline Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age

  June 5, 2007

   · 

  6 min read
• Drug Development

  Encouraging Clinical Activity of GlaxoSmithKline’s Novel Cancer Immunotherapeutic Confirmed in Phase II Study in Patients with Most Common Form of Lung Cancer

  June 5, 2007

   · 

  7 min read